Amgen Inc.
AMGN
$269.15
-$2.91-1.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.78B | 32.03B | 31.14B | 29.54B | 28.18B |
| Total Other Revenue | 1.35B | 1.40B | 1.39B | 1.39B | 1.35B |
| Total Revenue | 34.13B | 33.42B | 32.53B | 30.93B | 29.53B |
| Cost of Revenue | 9.86B | 9.77B | 11.51B | 10.01B | 8.58B |
| Gross Profit | 24.26B | 23.66B | 21.03B | 20.93B | 20.95B |
| SG&A Expenses | 6.98B | 7.10B | 7.01B | 6.73B | 6.24B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 157.00M | 164.00M | -679.00M | 48.00M | 155.00M |
| Total Operating Expenses | 23.10B | 22.99B | 23.61B | 22.19B | 20.05B |
| Operating Income | 11.02B | 10.44B | 8.93B | 8.75B | 9.48B |
| Income Before Tax | 6.65B | 4.61B | 4.68B | 3.53B | 4.35B |
| Income Tax Expenses | 717.00M | 519.00M | 449.00M | 395.00M | 582.00M |
| Earnings from Continuing Operations | 5.93K | 4.09K | 4.23K | 3.13K | 3.76K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.93B | 4.09B | 4.23B | 3.13B | 3.76B |
| EBIT | 11.02B | 10.44B | 8.93B | 8.75B | 9.48B |
| EBITDA | 16.49B | 15.92B | 14.36B | 13.68B | 13.92B |
| EPS Basic | 11.04 | 7.62 | 7.88 | 5.85 | 7.03 |
| Normalized Basic EPS | 9.19 | 8.57 | 6.43 | 6.71 | 7.10 |
| EPS Diluted | 10.96 | 7.55 | 7.81 | 5.81 | 7.00 |
| Normalized Diluted EPS | 9.11 | 8.51 | 6.39 | 6.66 | 7.06 |
| Average Basic Shares Outstanding | 2.15B | 2.15B | 2.15B | 2.14B | 2.14B |
| Average Diluted Shares Outstanding | 2.17B | 2.16B | 2.16B | 2.16B | 2.15B |
| Dividend Per Share | 9.13 | 9.00 | 8.88 | 8.76 | 8.64 |
| Payout Ratio | 82.64% | 118.14% | 112.70% | 150.06% | 122.96% |